CORRECTED-UPDATE 3-U.S. FDA approves Amgen drug for prevention of migraines
May 17, 2018 at 21:42 PM EDT
May 17 (Reuters) - Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults.